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Abstract: Aim: To identify activities that pharmacists undertake to reduce medication waste, and
to assess the extent to which these activities are implemented, their importance for waste-reduction
and feasibility for broad implementation. Methods: A two-phase survey was conducted among
community and hospital pharmacists working in different developed countries. Phase one used
an open-ended questionnaire to identify activities undertaken by pharmacists. Answers were
thematically analysed to construct a list of medication waste-reducing activities. In phase two,
a questionnaire was disseminated among pharmacists from different countries, to assess if these
activities are implemented (yes/no), their importance and feasibility (1 to 5 ranking scale). Results:
In phase one, 53 pharmacists participated and 14 activities were identified. These were categorized
into the pharmaceutical supply chain: prescribing, dispensing (pharmacy/patient-related) and
leftover stage. In phase two, 89 pharmacists participated. Most activities were implemented by a
minority of pharmacists. Reducing medication amounts in stock was most frequently implemented
(dispensing stage pharmacy-related; 86%), followed by collecting unused medications (leftover stage;
77%) and performing a medication review (dispensing stage; 68%). Waste-reducing activities in the
dispensing stage activities were both considered most important and feasible (ranked 4). Overall,
most activities scored higher on importance than on feasibility. Conclusions: Pharmacists have
various opportunities to reduce medication waste throughout the pharmaceutical supply chain,
however, not all are broadly implemented. Pharmacists consider waste-reducing activities important,
but they are less certain about the feasibility for implementation in practice.
Keywords: medication waste; unused medication; pharmacy practice; clinical pharmacy;
survey research
1. Introduction
Medication waste can occur in all stages of the pharmaceutical supply chain. For instance,
physicians may prescribe unnecessarily large quantities (prescribing stage). During the dispensing
stage, pharmacists dispense larger quantities as manufacturers’ package sizes may exceed the amount
required for treatment. Once medication has been supplied to the patient, early treatment changes,
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for example, due to some side effects or unsatisfactorily efficacy, can lead to an excessive amount of
unused medication at home. Moreover, low adherence of patients to treatment regimens can contribute
to medication waste as well. Finally, medications that are left unused and of good quality, are generally
destroyed if returned to the pharmacy [1–5].
There is increased awareness of the financial impact of medication waste [6–9]. Health care
budgets are limited and unused medications can be considered a waste of resources. It is important
that patients dispose of these properly, for instance, by returning these to pharmacies or chemical
waste depots. However, patients sometimes incorrectly dispose of unused medications through
household garbage, the toilet, or sink, with the risk of polluting the environment [10]. Active
pharmaceutical ingredients have been detected in surface, ground, and drinking water [11,12] that
may have detrimental effects on aquatic species and ecosystems [13,14]. Efforts to reduce medication
waste and the undesirable economic and environmental burden are, therefore, warranted.
Pharmacists are key players in the pharmaceutical supply chain and are in a position to contribute
to the reduction of medication waste [15]. One can presume that individual pharmacists have already
initiated various strategies to reduce this waste. However, information about activities that are
implemented in practice to reduce waste is limited. The availability of such information could facilitate
an exchange of knowledge between pharmacists on how to reduce medication waste and could
promote the implementation of such activities in daily practice. Therefore, the aim of this study was to
identify activities that individual pharmacists have currently undertaken in community and hospital
pharmacies in developed countries to reduce medication waste. Moreover, this study aimed to assess
the extent to which these activities are implemented, the importance of the activities for reducing
waste, and the feasibility for broadly implementing these activities in daily practice.
2. Materials and Methods
2.1. Study Design
This survey consisted of two phases: an exploratory phase of which the results were used for the
subsequent assessment phase. The study was conducted between July 2014 and October 2016. The first
phase aimed to identify activities currently undertaken by individual pharmacists and the second
phase aimed to assess the extent to which these activities are implemented and their importance and
feasibility (see Figure 1 for overview).
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2.3. Phase One: Exploration
2.3.1. Participants’ Inclusion and Data Collection
Pharmacists working in a community, hospital or academic setting located in a country with
a ranking of ‘very high‘ on the human development index [16] were eligible for participation.
Pharmacists were approached through (inter)national organizations of pharmacists or through the
personal network of the research group. Pharmacists received an email invitation explaining the
purpose of the study that included a link to the questionnaire. Non-responders received two reminders,
the first reminder was sent two weeks after the initial invitation and the second two weeks thereafter.
Countries were only included in the analysis if two pharmacists from that country completely filled in
the questionnaire.
2.3.2. Questionnaire
Activities that individual pharmacists have implemented to reduce medication waste were
explored by an open-ended questionnaire that was created in an online survey tool. The questionnaire
was developed by the research group and pre-tested in terms of interpretation by a pharmacist who
was not involved in the study. The questionnaire consisted of three sections (see Appendix A): the
prescribing, the dispensing and the leftover stage. Each section consisted of several questions that
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focused on activities implemented to reduce medication waste. As the community and hospital setting
may differ, hospital pharmacists were asked two additional questions regarding activities implemented
during the (preparation prior to) administration of medications and activities implemented at the
hospitals’ wards. Pharmacists’ country of origin and work setting (community pharmacy/hospital
pharmacy/academic) were recorded as well.
2.3.3. Data Analysis
Data from the questionnaires were exported to Microsoft Excel version 2010 (Microsoft,
Albuquerque, NM, USA) and analysed using thematic content analysis [17]. Pharmacists’ answers
were coded by the first researcher and reviewed by the second researcher [18]. Any disagreements
between the two researchers were discussed until consensus was reached. Hereafter, both researchers
independently categorized the activities into the three previous defined stages according to their
content which they subsequently discussed until both agreed.
2.4. Phase Two: Assessment of Implementation, Importance and Feasibility
2.4.1. Participants’ Inclusion and Data Collection
A questionnaire was constructed based on the results of the first phase. This questionnaire was
distributed among pharmacists participating in the 45th European Symposium on Clinical Pharmacy
that was held in Oslo, Norway, in October 2016. Only questionnaires completed by pharmacists
working in a country, as defined in phase one, were included in the analysis.
2.4.2. Questionnaire
Questions were formulated for all activities that were identified during the first phase of the
study and divided into the predefined stages (Appendix B). The questionnaire was also pre-tested by a
pharmacist not involved in the research study. For each activity, pharmacists were asked to indicate
whether the activity was implemented in their country (yes/no), to rank the importance of the activity
to reduce waste and the feasibility to implement in practice. Answers were measured on a scale with a
range from one, denoting the activity as not important or feasible, to five, very important or feasible.
In addition, pharmacists were able to add other activities if these were not included. Their country of
origin and work setting (community pharmacy/hospital pharmacy/academic/other) were recorded
as well.
2.4.3. Data Analysis
Data from the questionnaires were imported in Microsoft Excel and descriptively analysed
(frequencies and percentages). To equally weigh the frequency scores, more than 50% of the pharmacists
within a country should have reported implementing the activity, because activities taken by fewer
than half of the pharmacists within a country were assumed to be taken at random and therefore not
counted. The importance and feasibility ranking scales were assessed as medians with interquartile
ranges. First, the median ranking for each activity within each country was determined. Subsequently,
the median ranking for all activities were calculated and averaged per stage. All analyses were
performed in STATA version 13 (StataCorp, College Station, TX, USA) and Microsoft Excel.
3. Results
Fifty-three pharmacists from 19 developed countries were included in the first phase of the study
(Appendix C). The activities currently undertaken by individual pharmacists to reduce medication
waste were categorized into the prescribing, dispensing and leftover stage. During the analysis, two
subthemes within the dispensing stage were added, i.e., activities related to the pharmacy or to the
patient’s medication therapy and storage practices. In total, 14 main activities were identified (Table 1).
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Eighty-nine pharmacists from 22 developed countries were included in the second phase
(Appendix D). The pharmacists reported no new activities on top of the activities that were identified
in phase one. Results of the two phases are presented together per stage hereafter to facilitate a
comprehensive presentation.
Table 1. Waste-reducing activities that can be undertaken by pharmacists and their estimated
frequency of activities implemented to reduce medication waste. A country was considered to have
implemented an activity if more than 50% of the pharmacists within that country reported that the
activity is implemented.
Activity Countries(n = 22) n (%)
The prescribing stage
Prescribers tailor prescription amounts 7 (31.8)
Counsel prescribers on efficient prescribing 7 (31.8)
The dispensing stage
Pharmacy related
Pharmacists adjust prescribed amounts 10 (45.5)
Dispense opened medication package 11 (50.0)
Use dose-dispensing system 12 (54.5)
Manage medication amounts in stock 19 (86.4)
Limiting storage amounts 18 (94.7)
Exchange medications with other pharmacies 14 (73.7)
Pooling patients 7 (31.8)
Patient related
Store patient’s medications 2 (9.1)
Review patient’s medications 15 (68.2)
Discuss needed quantity 5 (22.7)
Use home medications during hospitalization 10 (45.5)
The leftover stage
Collect unused medications 17 (77.3)
Donate unused medications 4 (18.2)
Redispense unused medications 0 (0)
3.1. The Prescribing Stage
To reduce medication waste in the prescribing stage, two main activities that were undertaken
were identified. Namely, prescribers could tailor the prescribed amount and pharmacists could counsel
prescribers on the prescribed amount. Most pharmacists mentioned that prescribers tailor the amount
based on medication characteristics (e.g., cost), on patient characteristics (e.g., age) and the expected
duration of time until symptoms should resolve. Some pharmacists remarked that they counsel
prescribers on how to prevent waste. For instance, by recommending the duration of use for each
prescription whenever possible.
Activities in the prescribing stage were reported to be implemented by approximately one-third
of the countries (Table 1). On average, these activities were considered important for reducing waste
(median ranking 4), and were ranked neutral in terms of the feasibility of their implementation in
practice (median ranking 3, Figures 2 and 3).
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3.2. The Dispensing Stage
3.2.1. Pharmacy Related Activities
Activities undertaken by pharmacists to reduce medication waste in the dispensing phase focused
mainly on dispensing smaller amounts to the patient, by adjusting the amount of prescribed medications
to the treatment duration, dispensing opened medication packages and using dose-dispensing systems.
Most pharmacists indicated that the number of days for which medications can be dispensed is limited
by law and generally concerns a three-month supply. Some pharmacists mentioned that they are
allowed to adjust the amount of medications prescribed without consulting the prescriber. One example
of such an activity is when a pharmacist notices that a physician has prescribed more than needed, they
inform the patient and reduce the dispensed amount. However, this approach is not achievable for
all pharmacists as it was frequently reported that pharmacists are only allowed to dispense complete
medication packages, even when the prescribed amount is less. Concerning internal waste management
at the pharmacy, pharmacists mentioned that they manage the amount of medications kept in stock.
For example, some pharmacies exchange medications that are rarely used or that are close to the
expiry date to prevent disposal. In some hospital pharmacies, patients who are treated with parenteral
medications are scheduled on the same day in order to pool injection vials.
Stock management was most frequently reported activity implemented to reduce medication
waste, in 86.4% of the responding countries. Of these countries, 94.7% indicated that they limit
the amount of medications that are kept in stock and 73.7% collaborated with other pharmacies to
exchange medications. The other pharmacy-related activities of the dispensing stage were reported to
be implemented by approximately half of the countries. The activities were ranked the highest in terms
of importance and feasibility. Of all activities, using dose-dispensing systems and stock management
ranked highest concerning their importance for reducing waste (median ranking > 4), but lower on
feasibility for implementation (median ranking 3 and 4 respectively).
3.2.2. Patient-Related Activities
Patient-related activities for reducing waste reported in the dispensing stage aimed at optimizing
medication therapy and storage management by the patient. These include storing the majority of
patient’s medications at the pharmacy, reviewing the patient’s medications, and starting a dialogue with
the patient about the quantity needed. Furthermore, through discussion with the patient, pharmacists
try to adjust the dispensed amount to the patient’s actual needs, and to increase their awareness
about waste. Some hospital pharmacists reported that patients are allowed to use their own home
medications during hospital admission, thereby reducing medication waste.
Sixty-eight percent of the responding countries reported to perform medication reviews. Only
9.1% of the countries stored patients’ medications at the pharmacy and this was considered less
feasible (median ranking 2). Overall, patient-related activities in the dispensing stage were considered
important for reducing waste (median ranking 4), but scored lower on feasibility for implementation
(median ranking 3).
3.3. The Leftover Stage
Three waste-reducing activities were identified in the leftover stage. Community and hospital
pharmacists mentioned that the amount of unused medications is collected in the pharmacy for safe
disposal. A few pharmacists indicated that these medications are donated to charities for people in
need. As a last activity, hospital pharmacists mentioned that unused medications were redispensed,
under the condition that the medications were stored at the hospital ward and had not been dispensed
to patients.
Of the responding countries, 77.3% reported collecting unused medications and 18.2% donating
unused medications. None of the countries reported redispensing unused medications returned by
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patients. Activities aimed at tackling medication waste during the leftover stage scored lowest in terms
of both importance and feasibility (median rankings 3).
4. Discussion
This study shows that pharmacists undertake several activities to limit medication waste in all
stages of the pharmaceutical supply chain. More than half of the participating countries reported
using dose-dispensing systems, managing the amount of medication in stock, performing medication
reviews, and collecting unused medications. Pharmacists considered activities of the prescribing and
dispensing stage most important for reducing medication waste and pharmacy-related activities of the
dispensing stage most feasible for implementation in practice. Most activities scored lower in terms of
feasibility than importance.
This is the first study that gives an overview of activities taken by community and hospital
pharmacists. For this study, several limitations could be identified. Most importantly, only pharmacists
were consulted. It is possible that other healthcare professionals would identify other medication
waste-reducing activities. Also, not all pharmacists of the countries approached responded to the
survey, hence, some activities might have been missed. However, no additional activities were
mentioned in the second phase of the study that included other countries as well. Therefore,
one can assume that the list of potential activities to reduce waste is comprehensive. Third, the
second researcher was not blinded for the coding of the first researcher. However, the pharmacists
mentioned concrete activities and thus the risk of misclassification is considered minimal. Fourth,
not all questionnaires were fully completed. We found that the reported answers of uncompleted
questionnaires did not differ from the fully completed questionnaires. Hence, it is assumed that the
missing answers would not have altered the findings. Fifth, the respondents and the activities they
reported might not necessarily be representative for their whole country. However, it still enabled us
to report on activities that pharmacists have implemented to reduce medication waste and to indicate
which activities are implemented most frequently. Sixth, only activities implemented by the majority
of pharmacists within a country were considered to be implemented by that country. This could have
resulted in an underestimation of the frequency that activities were taken. Finally, this study involved
pharmacists working in developed countries, and any generalization of our results with respect to
other countries should be viewed with caution.
Many pharmacists considered the waste-reducing activities as important, which emphasizes the
necessity for interventions that aim to combat medication waste. The study suggests that activities
that are related to the organization of the pharmacy and the dispensing stage were most often
implemented and were considered most feasible. Overall, activities that focus on waste prevention
were found to be most promising. But as not all activities were considered achievable to implement
in practice, this may suggest that barriers hamper feasible implementation and a need for feasible
waste-reducing interventions. Looking at the current evidence of potential interventions, an example
of a waste-reducing activity in the prescribing stage is to dispense smaller amounts of expensive
medications. Limiting the amount of medication supplied for a first time to a two-week period,
followed by 30 days for a repeat prescription [19], may decrease the risk of unused medications and
unnecessary waste. Patients receiving medications for more than 30 days are more likely to waste
a part of those medications [20,21]. Additionally, pharmacists could also supply a trial prescription
amount to the patient at the start of treatment and supply the remainder when the medication is well
tolerated. Paterson et al. showed that a split-fill supply could reduce the cost of medication waste [22].
Regarding the dispensing stage, studies show that increasing the frequency of medication batch
preparations or scheduling patients with the same therapy on the same day in the hospital pharmacy
could reduce medication waste and expenditures [23–25]. However, applying such strategies in the
community pharmacy is not financially feasible as large quantities of relatively low-cost medications
are generally dispensed and additional dispensing fees may outweigh the savings on medication
costs [26]. Pharmacists should, therefore, consider the individual medication costs when deciding if
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smaller amounts should be dispensed to the patient, as this may not always save costs, however, it
might still reduce the risk of environmental pollution.
It is important not to focus on waste reduction by prescribers and pharmacists but also to increase
patients’ awareness of medication waste. Patients often only pay a part of the medication cost out
of pocket and are not always aware of the total cost of medication. Governments and health care
authorities have started campaigns to raise patients’ awareness about medication prices, including
displaying the price on the medication package or on the dosage label [27]. Furthermore, discussing
the quantity dispensed with the patient could reduce the supply of unwanted medications and,
potentially, medication waste [28]. If adherence of patients to their treatment regimen could be
increased, medication waste might be reduced as well. Moreover, medication reviews could be
periodically conducted to identify medication therapies that are dispensed to patients but no longer
needed or non-adherence. Unnecessary medication therapies could thereby be discontinued helping to
reduce the waste of unnecessary healthcare costs. Regarding the leftover stage, very few interventions
have been investigated and most studies assess the amount and economic value of medications
returned to pharmacies [2,4,29–31]. The donation of medications to other countries is disapproved of
by the World Health Organization [32]. The question as to whether medications returned to pharmacies
could be redispensed remains hypothetical [33,34], as many prerequisites need to be addressed in
order to redispense unused medications, such as how to ascertain the quality of the medications, the
patients trust in redispensed medications, and the legal- and financial feasibility [35,36].
Multiple interventions seem promising for reducing medication waste. However, it seems
that various barriers hamper their implementation. Barriers one could think of are each nation’s
reimbursement systems which influence how medications are prescribed, dispensed and collected at
the pharmacy. Furthermore, legislation could be challenging to the implementation of waste-reducing
activities. Some of the respondents reported that different activities, such as splitting packages into
smaller quantities, are not legally allowed. Even within a country, pharmacists can counteract waste
differently as this will also depend on the availability of resources in the pharmacy, like sufficient
knowledge of pharmacy workers of the possibilities to reduce medication waste and the monetary
budget. For the successful implementation of waste-reducing interventions, such barriers should be
identified and overcome first.
5. Conclusions
This study demonstrates that pharmacists have developed many activities to reduce medication
waste in all stages of the pharmaceutical supply chain. However, not all potential activities to reduce
medication waste have been implemented in daily practice. Activities focusing on waste prevention
seem most promising. Even though pharmacists consider activities for reducing medication waste
important, they are less certain about the feasibility of broadly implementing these activities in daily
clinical practice.
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Appendix A. Questionnaire of Phase One
1. Which initiatives are taken nationally and in pharmacies to minimize medication waste?
 Initiatives taken by prescribers.
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 Initiatives taken in the pharmacy during dispensing.
 Initiatives taken for leftover unused medications.
Prescribing stage
2. Which phases are taken by prescribers to minimize medication waste?
3. In which cases is the number of drugs prescribed tailored on a patient’s health condition?
4. In which cases is the number of drugs prescribed tailored on costs or on other drug characteristics?
Dispensing stage
5. Which initiatives are taken in pharmacies during the dispensing of medications?
6. What is the maximum amount of days for which medications can be dispensed in your country?
7. Which initiatives are taken at the different departments of the hospital?
8. Which initiatives are taken in the hospital pharmacy while preparing/compounding
the medication?
Leftover stage
9. What is done with unused medications that are returned to the pharmacy?
Appendix B. Questionnaire of Phase Two
Activity Taken
in Your
Country
Important for
Decreasing
Medication
Waste
Feasible to
Implement in
Practice
Yes No 1 (Not)–5 (Very) 1 (Not)–5 (Very)
The prescribing stage
Do prescribers tailor the amount of medications that they
prescribe in order to limit medication waste?
Do pharmacists counsel physicians on how to combat potential
medication waste?
The dispensing stage
Are pharmacists allowed to adjust the prescribed amount
during dispensing in order to limit potential medication waste?
Are pharmacist allowed to remove medication from the original
package in order to limit potential medication waste (e.g., split
packages)?
Are pharmacists using (unit) dose dispensing systems?
Are pharmacists managing the amount of medications that is
kept in stock in the pharmacy in order to limit medication
waste? If yes, how?
# Limiting the amount that is kept in stock.
# Collaborating with other pharmacies to exchange almost
expired medications.
# Other:
Are pharmacists in the hospital pharmacy scheduling patients
on the same day so that medication is prepared at once in order
to limit medication waste (e.g., pooling of patients with IV
drugs)?
Please explain other actions taken during dispensing that limit
medication waste:
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Optimizing stock management by the patient
Are pharmacists enabling patients to store a part of their
prescribed medications in the pharmacy?
Are pharmacists reviewing patient’s medications in order to
limit medication waste (e.g., medication review, optimization of
pharmacotherapy)?
Are pharmacists discussing the quantity needed for symptom
improvement with the patient in order to limit medication
waste (increase awareness about waste)?
Are patients allowed to bring their home medication to the
hospital and use this during hospitalization?
Please explain other actions discussed during patient’s
counselling that limit medication waste:
The leftover stage
Are pharmacists collecting unused medications so they can
dispose of them safely?
Are pharmacists allowed to donate unused medications that are
returned to the pharmacy to other countries or people in need?
Can unused medications that are returned to pharmacies by
patients be re-dispensed to a different patient?
# If yes, do the returned medications need to apply with
specific criteria? Which criteria?
Appendix C. Number of Pharmacists per Country of Origin and Work Setting that Participated in
Phase One
n = 19 Total n = 53
Community Pharmacy
n = 39
Hospital Pharmacy
n = 14
Australia 2 2
Belgium 4 3 1
Canada 2 2
Croatia 2 2
Denmark 3 2 1
Estonia 5 4 1
Finland 2 1 1
France 2 1 1
Iceland 8 8
Ireland 2 1 1
Italy 2 2
Malta 2 1 1
Netherlands 4 3 1
New Zealand 2 1 1
Norway 2 1 1
Spain 2 2
Switzerland 3 2 1
United Kingdom 2 2
United States 2 1 1
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Appendix D. Number of Pharmacists per Country of Origin and Work Setting That Participated
in Phase Two. 12 Pharmacists Were Working in Multiple Settings and therefore the Total Sum
Exceeds 89
n = 22 Total n = 89
Community Pharmacy
n = 13
Hospital Pharmacy
n = 66
Academic
n = 15
Other n = 7
Australia 1 1
Austria 11 11 1
Belgium 2 2
Canada 2 2 1
Croatia 1 1
Denmark 1 1 1
Estonia 2 2
Finland 1 1
France 6 6 2
Germany 2 2 1
Ireland 1 1
Italy 2 2
Netherlands 5 2 1 1 1
Norway 24 21 2 1
Portugal 4 1 2 1 1
Romania 2 2
Slovakia 1 1
Slovenia 4 3 1
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